Patients Who Have Bilateral NanoFlex Implantation at Least 3 Months Previously
Conditions
Brief summary
The purpose of this study is to look at how well you see the Nanoflex Intraocular lens placed in your eye.
Interventions
DEVICENanoflex IOL
Patients who were implanted with the Nanoflex IOL
Sponsors
Innovative Medical
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Male or female patients at least 18 years of age. * Patients who have bilateral NanoFlex implantation at least 3 months previously. * No significant ocular pathology causing DCVA to be less than 20/25 or causing significant visual loss. * DCVA of 20/25 or better in both eyes. * Spherical equivalent in the dominant eye to be +/-.50 or less and in the non-dominant eye to be between-1.00 and -1.87. * Uncorrected VA in dominant eye 20/25 or better.
Exclusion criteria
* History of ocular trauma or prior ocular surgery (minor ocular trauma is allowed such as small superficial corneal scar not effecting vision; some prior ocular surgery is allowable so long as it has not impacted visual acuity. * Amblyopia or strabismus, significant visual field loss, or posterior capsular opacifcation. * Known pathology that may affect visual acuity; particularly retinal changes that affect vision (macular degeneration, cystoid macular edema, proliferative diabetic retinopathy, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uncorrected Near Visual Acuity | 1 year |
Countries
United States
Contacts
Primary ContactAnnie Christensen
Outcome results
None listed